StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) stock

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06+0.00 (0.00%)

Close on Nov 19, 2026Market cap $14.81MP/E –Yield –

Estrella Immunopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Estrella Immunopharma

Estrella Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Estrella Immunopharma figures

See a number that looks wrong?